Related Experiment Video
Updated: Dec 3, 2025

Fabrication of Size-Controlled and Emulsion-Free Chitosan-Genipin Microgels for Tissue Engineering Applications
Published on: April 13, 2022
Third-Generation Cephalosporin-Loaded Chitosan Used to Limit Microorganisms Resistance
Letiția Doina Duceac1,2, Gabriela Calin1, Lucian Eva1,2
1Faculty of Dental Medicine, "Apollonia" University of Iasi, 11 Pacurari Str., 700511 Iasi, Romania.
Abstract:
From their discovery, antibiotics have significantly improved clinical treatments of infections, thus leading to diminishing morbidity and mortality in critical care patients, as well as surgical, transplant and other types of medical procedures. In contemporary medicine, a significant debate regarding the development of multi-drug resistance involves all types of pathogens, especially in acute care hospitals due to suboptimal or inappropriate therapy. The possibility of nanotechnology using nanoparticles as matrices to encapsulate a lot of active molecules should increase drug efficacy, limit adverse effects and be an alternative helping to combat antibiotic resistance. The major aim of this study was to obtain and to analyze physico-chemical features of chitosan used as a drug-delivery system in order to stop the antibiotic resistance of different pathogens. It is well known that World Health Organization stated that multidrug resistance is one of the most important health threats worldwide. In last few years, nano-medicine emerged as an improved therapy to combat antibiotic-resistant infections agents. This work relies on enhancement of the antimicrobial efficiency of ceftriaxone against gram(+) and gram(-) bacteria by antibiotic encapsulation into chitosan nanoparticles. Physicochemical features of ceftriaxone-loaded polymer nanoparticles were investigated by particle size distribution and zeta potential, Fourier-transform infrared spectroscopy (FTIR), Thermal Gravimetric Analysis (TG/TGA), Scanning Electron Microscopy (SEM) characteristics techniques. The obtained results revealed an average particle size of 250 nm and a zeta potential value of 38.5 mV. The release profile indicates an incipient drug deliverance of almost 15%, after 2 h of approximately 83%, followed by a slowed drug release up to 24 h. Characteristics peaks of chitosan were confirmed by FTIR spectra indicating a similar structure in the case of ceftriaxone-loaded chitosan nanoparticles. A good encapsulation of the antibiotic into chitosan nanoparticles was also provided by thermo-gravimetric analysis. Morphological characteristics shown by SEM micrographs exhibit spherical nanoparticles of 30-250 nm in size with agglomerated architectures. Chitosan, a natural polymer which is used to load different drugs, provides sustained and prolonged release of antibiotics at a specific target by possessing antimicrobial activity against gram(+) and gram(-) bacteria. In this research, ceftriaxone-loaded chitosan nanoparticles were investigated as a carrier in antibiotic delivery.
Insights
This study developed chitosan nanoparticles to enhance the antibiotic ceftriaxone
Area of Science:
- Nanomedicine
- Polymer Science
- Microbiology
Background:
- Antibiotic resistance is a major global health threat, necessitating novel therapeutic strategies.
- Nanotechnology offers potential solutions by improving drug efficacy and reducing adverse effects.
- Chitosan nanoparticles are explored as a drug delivery system to combat resistant pathogens.
Purpose of the Study:
- To synthesize and characterize ceftriaxone-loaded chitosan nanoparticles.
- To evaluate the physicochemical properties and drug release profile of the nanoparticles.
- To assess the potential of these nanoparticles in combating antibiotic resistance.
Main Methods:
- Physicochemical characterization using particle size distribution, zeta potential, FTIR, TGA, and SEM.
- Encapsulation of ceftriaxone antibiotic into chitosan nanoparticles.
- In vitro drug release studies over 24 hours.
Main Results:
- Synthesized nanoparticles with an average size of 250 nm and a zeta potential of 38.5 mV.
- Confirmed successful encapsulation and structural integrity of ceftriaxone within chitosan nanoparticles via FTIR and TGA.
- SEM revealed spherical nanoparticles ranging from 30-250 nm.
- Drug release profile showed sustained release, with ~83% released by 2 hours and prolonged release up to 24 hours.
Conclusions:
- Chitosan nanoparticles effectively encapsulate ceftriaxone, enhancing its delivery.
- The developed nanoparticles exhibit favorable physicochemical properties and sustained drug release.
- This nanomedicine approach shows promise for combating antibiotic resistance in Gram-positive and Gram-negative bacteria.
Related Concept Videos
Hand hygiene
Hand washing...
Antimicrobial Effectiveness
Development of Antibiotic Resistance
Surface Membrane Barriers
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention

